Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients
Cancer Biology and Therapy - United States
doi 10.1080/15384047.2016.1235660
Full Text
Open PDFAbstract
Available in full text
Date
September 16, 2016
Authors
Publisher
Informa UK Limited